In a report released today, from Oppenheimer maintained a Hold rating on Amedisys. The company’s shares opened today at $99.23. Elevate Your Investing Strategy: Take advantage o ...

UnitedHealth will divest 164 healthcare locations and Amedisys will pay a $1.1 million penalty under a DOJ settlement ...

Thursday’s settlement is weaker than at least one antitrust expert expected based on the severity of the DOJ’s concerns. But ...

UnitedHealth Group has agreed to sell off 164 hospice and home health locations to resolve U.S. antitrust concerns over its ...

The Department of Justice and state officials have reached a proposed settlement agreement with UnitedHealth Group and ...

The settlement filed with the Maryland district court on Thursday requires UnitedHealth and Amedisys to divest 164 home ...

The proposal, if approved, would end the legal battle that followed the DOJ's lawsuit to stymie UnitedHealth and Amedisys' ...

UnitedHealth Group and home health company Amedisys have reached a settlement with the federal government that will allow ...

Unitedhealth Group Inc. and home health and hospice care company Amedisys Inc. have reached a proposed a settlement with the ...

In November, the DO J filed a lawsuit to challenge Amedisys' (NASDAQ: AMED) $101 a share sale to UnitedHealth (NYSE: UNH ...

The U.S. Justice Department said on Thursday it required broad divestitures to resolve a challenge to Unitedhealth’s $3.3 ...